Bioengineered yeast mass produces herbal medicine
Briefly

The production of artepillin C, a compound with multiple health benefits, has been increase tenfold by Kobe University's bioengineered yeast through optimizing the molecular production process.
According to HASUNUMA Tomohisa, producing herbal compounds via bioengineered microorganisms is vital for achieving high-yield, affordable supply, overcoming mass production challenges.
Identification of the specific plant enzyme for artepillin C, discovered by YAZAKI Kazufumi, unlocked the potential for microbial production in yeast, making it viable for larger scale production.
The bioengineered yeast Komagataella phaffii has shown to be superior for industrial production of artepillin C, as it can grow in higher densities without alcohol interference.
Read at ScienceDaily
[
|
]